Maximize the value of your asset at phase II clinical milestones.

Our experts know the importance of Phase II clinical milestones, including proof of concept efficacy, dosing and initial benefit-risk assessment. Positive trial outcomes will likely require investment in carefully considered activities delivered with precision to maximize value creation.

With expert Advisory, Medical, MarComms, and Engagement services, coordinated through a single strategic point of contact, we have the expertise required to help you maximize the value of your asset when you receive positive Phase II data readouts.

Explore Inizio Biotech

Key Phase II services.

Our services are highly personalized to the scope and scale you require. These are some common services we deliver to companies with Phase II assets:

Scientific communication platform to underpin all communications activities 

Key Opinion Leader (KOL) mapping and engagement including Digital Sphere of Influence (DOL)

Experience maps including patient journey, practice standards and buying process

Value, pricing and access including forecasts for investors and create access-focused value proposition

Evidence generation plan to maximize future investments 

Maximize tomorrow.

Maximizing your next value creation opportunity is within reach, start a conversation with one of our subject matter experts and access the expertise you need today.